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Abstract Botulinum toxin (BTX) is a neurotoxin used in
medicine as an effective drug in experimental therapy of
neurogenic urinary bladder disorders. We have investigated
the influence of BTX on the chemical coding of sympathetic
chain ganglia (SChG) neurons supplying the porcine urinary
bladder. The toxin was injected into the wall of the bladder.
SChG neurons were visualized by a retrograde tracing method
with fluorescent tracer fast blue (FB) and their chemical
coding was investigated by double-labelling immunohisto-
chemistry with antibodies against dopamine β-hydroxylase
(DβH; a marker of noradrenergic neurons), neuropeptide Y
(NPY), vasoactive intestinal polypeptide (VIP), somatostatin
(SOM), galanin (GAL), Leu5-enkephalin (L-ENK) and neu-
ronal nitric oxide synthase (nNOS). In both the control (n=5)
and BTX-treated pigs (n=5), the vast majority (91±2.3 % and
89.8±2.5 %, respectively) of FB-positive (FB+) nerve cells
were DβH+. BTX injections caused a decrease in the number
of FB+/DβH+ neurons that were immunopositive to NPY
(39.5±4.5 % vs 74.5±11.9 %), VIP (8.9±5.3 % vs 22.3±
8.8%), SOM (5.8±2.3% vs 17.4±3.7%) or GAL (0.9±1.2%
vs 5.4±4.4 %) and a distinct increase in the number of FB+/
DβH+ neurons that were immunoreactive to L-ENK (3.7±
2.9 % vs 1.1 %±0.8 %) or nNOS (7.7±3.5 % vs 0.8±0.6 %).
Our study provides novel evidence that the therapeutic effects
of BTX on the mammalian urinary bladder are partlymediated
by SChG neurons.
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Introduction
Botulinum toxin (BTX), produced by the anaerobic bacterium
Clostridium botulinum (van Ermengem 1897), is one of the most
potent neurotoxins known. It acts by entering the presynaptic
bulb of cholinergic neurons and by inhibiting acetylcholine
(ACh) release as a result of the prevention of normal vesicle
docking and fusion to the presynaptic plasma membrane
(Haferkamp et al. 2004). To date, the toxin has been proposed
for the treatment of numerous neurogenic dysfunctions, charac-
terized by excessive or inappropriatemuscle contractions, such as
strabismus, blepharospasm or muscular dystonias (for reviews,
see Carruthers and Carruthers 2004; Lowe and Lowe 2012).
For several years, BTX has also been used as an effective
drug in experimental therapies of a range of neurogenic uri-
nary bladder disorders and, since the end of 2011, it has been
approved for the treatment of urinary incontinence secondary
to neurogenic detrusor activity (Cruz et al. 2011). The litera-
ture in the field contains many contributions regarding the
possible clinical use of BTX in urology (see Rohrsted et al.
2012; Pinto et al. 2013; Santos-Silva et al. 2013).
Because of the mechanism of its action, BTX apparently
influences parasympathetic/cholinergic neurons that supply
the urinary bladder and that, through the release of ACh,
activate muscarinic receptors and mediate the contraction of
the detrusor muscle (Thüroff et al. 1982), thereby causing
bladder emptying and micturition (Levin et al. 1986). The
toxin is well known to affect sensory neurotransmission and
has analgesic properties in animals and humans, as has been
demonstrated in many morphological, functional and clinical
studies (see Bossowska and Majewski 2012; Kuo 2013; Pinto
et al. 2013; Matak et al. 2014). Moreover, BTX appears to
influence the urothelial release of adenosine triphosphate
(ATP; Collins et al. 2013; Hanna-Mitchell et al. 2013).
However, the proper storage and elimination of urine are also
largely dependent upon the activity of the sympathetic/
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noradrenergic supply. The noradrenergic efferent pathways
facilitate relaxation of the detrusor muscle via β-
adrenoreceptors and excite the bladder base and urethra via
α1-adrenoreceptors, thus achieving continence (Andersson
and Arner 2004; Morrison et al. 2005). Notably, some infor-
mation suggests that BTX can affect noradrenergic transmis-
sion in the lower urinary tract (Smith et al. 2003; Wojtkiewicz
et al. 2008; Lepiarczyk et al. 2011).
The sympathetic noradrenergic innervation of the urinary
bladder arises from various sources (for reviews, see Jobling
2011; de Groat and Wickens 2013) including the sympathetic
chain ganglia (SChG), inferior mesenteric ganglion (IMG),
pelvic ganglia (considered as mixed autonomic ganglia
consisting of both sympathetic and parasympathetic cells;
Keast 1992) and intramural ganglia of the urinary bladder
(which contain some noradrenergic neurons; Downie et al.
1984). In females, however, SChG are considered to provide a
great (or maybe the greatest) contribution to the bladder
noradrenergic nerve supply and most of this innervation sup-
plies blood vessels (Chien et al. 1991; Houdeau et al. 1998).
Vera and Nadelhaft (1992) have revealed that, in the female
rat, the largest part of the sympathetic innervation of the
bladder dome and base arises from the SChG (77 % and
89 %, respectively), and not from the IMG.
The thorough analysis of the literature suggests that the
administration of BTX into the urinary bladder wall can evoke
a plastic response of bladder-projecting noradrenergic neu-
rons, as reflected by changes in their chemical coding
(Wojtkiewicz et al. 2008; Lepiarczyk et al. 2011). Studies
dealing with the problem of the plasticity of particular neuro-
nal populations have often involved combined retrograde
tracing and immunohistochemistry (Kaleczyc et al. 1995;
Bossowska and Majewski 2012; Pidsudko 2014). However,
the information concerning the plastic response of sympathet-
ic neurons supplying the mammalian urinary bladder to the
BTX treatment gained with these methods is extremely limit-
ed. Only one congress abstract (Wojtkiewicz et al. 2008) is
available reporting changes in the chemical coding of IMG
urinary bladder projecting neurons (UBPN) after intravesical
toxin administration in the domestic female pig and no such
investigations regarding the population of UBPN in SChG
have been performed so far.
Therefore the present study has been designed to investi-
gate the chemical coding of neurons in the SChG projecting to
the urinary bladder in normal (intact) pigs and in BTX-treated
pigs by using combined retrograde tracing and double-
labelling immunohistochemistry. As BTX is nowadays ap-
plied in the therapies of a range of neurogenic urinary bladder
disorders in humans, and as the prevalence of these syndromes
is clearly higher in women compared with men (Terai et al.
2004), we have examined female animals in the present re-
search. We have decided to employ domestic pigs in our
experiments, since they are one of the major animal species
used in biomedical research and because they share with
humans similar anatomical and physiological characteristics
involving the urinary, cardiovascular, integumentary and di-
gestive systems (e.g., Dalmose et al. 2000; Kuzmuk and
Schook 2011; Swindle et al. 2012).
Materials and methods
Laboratory animals
The study was performed on 10 juvenile (8–12 weeks old, 15–
20 kg body weight, b.w.) female pigs of the Large White
Polish race. The animals were kept under standard laboratory
conditions. They were fed standard fodder (Grower Plus,
Wipasz, Wadąg, Poland) and had free access to water.
Before any surgical procedure were performed, all the pigs
were pretreated with atropine (Polfa, Poland, 0.04 mg/kg b.w.,
s.c.) and propionylpromasine (Stresnil, Janssen Pharmaceutica,
Belgium, 0.5 mg/kg b.w., i.m.), and after 30 min, the main
anaesthetic drug, sodium pentobarbital (Tiopental, 0.5 g per ani-
mal), was given intravenously in a slow fractionated infusion. The
depth of anaesthesia was monitored by testing the corneal reflex.
The animals were housed and treated in accordance with
the rules of the local Ethics Commission (affiliated to the
National Ethics Commission for Animal Experimentation,
Polish Ministry of Science and Higher Education).
Surgical procedures
In all the pigs, a mid-line laparotomy was performed and the
urinary bladder was gently exposed to administer a total
volume of 40 μl of a 5 % aqueous solution of the fluorescent
retrograde tracer Fast Blue (FB; Dr K. Illing, Gross Umstadt,
Germany) into the wall of its right side in multiple injections.
To avoid any leakage, the needle was left in situ for about
1 min. The wall of the injected organ was then rinsed with
physiological saline and gently wiped with gauze.
Three weeks later (the optimal time for the retrograde tracer
to be transported to the SChG and to label UBPN; Bossowska
et al. 2009), the pigs were divided into two groups. One group
of 5 pigs served as controls and were injected (multiple
injections) into the wall of the right side of the urinary bladder
with 40 μl aqueous saline solution by using a cystoscope.
Another group of 5 pigs was injected (multiple injections) into
the wall of the right side of the urinary bladder with BTX type
A (Botox, 100 IU, 40 μl) by using a cystoscope in order to
mimic the route of its administration used in humans.
One week after the administration of the aqueous saline
solution or BTX, all the pigs were deeply anaesthetized with
sodium pentobarbital and transcardially perfused with 4 %
buffered paraformaldehyde (pH 7.4). Three pigs studied had
14 ribs, five animals had 15 ribs and two animals had 16 ribs
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and, thus, they had 14, 15 or 16 thoracic (Th) SChG, respec-
tively. All Th, lumbar (L) and sacral (S) SChG were collected
(i.e. 14–16 Th, 6 L and 4 S), post-fixed in the same fixative
(10 min at room temperature), washed several times in 0.1 M
phosphate buffer and stored in 18 % buffered sucrose at 4 °C
until being used for sectioning.
Sectioning of ganglia and estimation of total number
of SChG-UBPN
The SChG were cut with a HM525 Zeiss cryostat into 10-μm-
thick serial sections. To calculate the number of FB-positive
(FB+) perikarya, they were counted in every fourth section to
avoid double-counting of the same neuron (most neurons
were approximately 40 μm in diameter). Only neurons with
a clearly visible nucleus were considered.
The total numbers of nerve cells counted in the SChG and
the relative frequencies of perikarya in the ganglia from either
side of each segmental level are presented as means±standard
deviation (SD).
Immunohistochemical procedure
Immunohistochemistry involved double-staining that was per-
formed according to a method described earlier (Bossowska
andMajewski 2012) and was applied to cryostat sections from
both the ipsi- and contralateral L3 and L5 ganglia and from the
S2 ganglia, because these ganglia were found to contain the
highest numbers of FB+ neurons. The sections were selected
from three different representative regions of the ganglia
(upper one-third, middle and lower one-third).
Immunohistochemical characteristics of FB+ neurons were
investigated by using primary antibodies against dopamine β-
hydroxylase (DβH; marker of noradrenergic neurons), neuro-
peptide Y (NPY), vasoactive intestinal polypeptide (VIP), so-
matostatin (SOM), galanin (GAL), Leu5-enkephalin (L-ENK)
and neuronal nitric oxide synthase (nNOS; for details concerning
all the primary and secondary antibodies used, see Table 1). DβH
antiserum was applied in a mixture with antisera against NPY,
VIP, SOM, GAL, L-ENK or nNOS. The presence of the above-
mentioned active substances (NPY,VIP, SOM,GAL, L-ENK) or
their markers (DβH, nNOS, namely enzymes of the catechol-
amine or nitric oxide biosynthesis pathway, respectively) was
previously revealed in the SChG neurons of pig (Skobowiat et al.
2011; Ragionieri et al. 2013; Pidsudko 2014).
The application of antisera raised in various species allowed
investigation of the coexistence of DβH with other substances.
Retrogradely labelled and immunohistochemically investigated
perikarya were evaluated under an Olympus BX61 microscope
equipped with an epifluorescence filter and an appropriate filter
set for CY3 and fluorescein isothiocyanate (FITC).
To determine percentages of the particular neuronal sub-
populations, at least 200 FB+ neuronal profiles investigated
with one combination of the primary antisera for the
coexpression of the biologically active substances were count-
ed in each ganglion studied (bilateral L3, L5 and S2); thus, at
least 600 neurons were analysed for one coexistence pattern of
the neurotransmitters in every animal. In both the control and
BTX-treated animals, the percentages of the retrogradely la-
belled neurons immunopositive to particular biologically ac-
tive substances or their markers investigated were pooled and
presented as means ± SD.
Micrographs were taken by using an Olympus XM10 digital
camera. The microscope was equipped with cellSens Dimension
Image Processing software. Morphometric data relative to each
neuronal class were compared within each animal and among
animals and were analysed by the Student t-test by using
GraphPad PRISM 4.0 software and by Pearson’s Chi-squared
test with Yates’ continuity correction. Differences in both tests
were considered to be significant at P<0.05.
Control of specificity of tracer staining
and immunohistochemical procedures
Thoroughmacroscopic examinations of the sites of FB injections
and the tissues adjacent to the urinary bladder were performed
before the collection of information from the ganglia. The sites of
the injections were easily identified by the yellow-labelled depo-
sition left by the tracer within the bladder wall. Moreover, the
injection sites were also observed under UV lamp rays in the
dark room. The tissues adjacent to the bladder were not found to
be contaminated with the tracer. To verify that the tracer had not
migrated into the urethra, we analysed, in cryostat sections and
by means of the haematoxylin and eosin staining technique, the
junction between the urinary bladder trigone and cranial portion
of the urethra. In all the animals studied, no contamination of the
tracer was found within the urethra. All these procedures exclud-
ed any leakage of the tracer and validated the specificity of the
tracing protocol.
Standard controls, i.e. preabsorption for the neuropeptide
antisera (20 μg appropriate antigen per 1 ml corresponding
antibody at working dilution; all antigens purchased from
Peninsula, Sigma or Dianova, Fig. 1) or omission and replace-
ment of the respective primary antiserumwith the correspond-
ing non-immune sera, completely abolished immunofluores-
cence and eliminated specific staining.
Results
Distribution of FB+ neurons in control and BTX-treated pigs
After injection of FB into the wall of the right side of the
urinary bladder, FB+ neurons were found distributed in the
bilateral Th, L and S SChG, from the last two Th ganglia to the
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S3 ganglia in all the pigs. Distinct left-right differences were
observed as the vast majority of the neurons in both control
and BTX-treated animals were found in the right and thus
ipsilateral ganglia. In control pigs, 1364±154.6 FB+ neurons
(16.5±2.9 %) were found in the left SChG and 7011±935.1
neurons (83.5±2.9 %) were found in the right SChG. In the
BTX-treated animals, 1199±97.6 FB+ neurons (14.5±2.1 %)
were found in the left SChG and 7133±652.9 FB+ neurons
(85.5±2.1 %) were found in the right SChG. Moreover, in
both the control and experimental pigs, the right L3, L5 and
S2 ganglia appeared to contain distinctly more FB+ neurons
than each of the other ganglia. The relative frequency of FB+
neurons in the particular SChG of the control and BTX-treated
animals is shown in Fig. 2.
The labelled neurons were isolated or sometimes clustered
in small groups of 2–3 cells scattered throughout the individ-
ual ganglia. In the ganglia containing the highest number of
FB+ neurons, the retrogradely labelled cells were distributed
evenly. In the ganglia containing smaller numbers of FB+
perikarya, the neurons were almost exclusively distributed
close to and along the ganglionic border.
Immunohistochemical characteristics of FB+ neurons
in control pigs
Double-labelling immunohistochemistry revealed two main
populations of FB+ neurons. The vast majority (91±2.3 %)
of the retrogradely labelled nerve cells were DβH-positive
(DβH+; Fig. 3b, e, h, k, n). The remaining FB+ neurons (9±
2.3 %) were DβH-negative (DβH-; Fig. 3b, h).
Among the FB+/DβH+ neurons, many (74.5±11.9 %)
perikarya also stained for NPY (Fig. 3a–c). Some of the
FB+/DβH+ neurons were immunopositive to VIP (22.3±
8.8 %; Fig. 3d–f) or SOM (17.4±3.7 %; Fig. 3g–i). A small
number (5.4±4.4 %) of FB+/DβH+ nerve cells expressed
immunoreactivity to GAL. Single FB+/DβH+ neuronal
Fig. 1 Representative images of sympathetic chain ganglia urinary
bladder-projecting neurons (SChG-UBPN) in control pigs. Micrographs
were taken separately from the blue fluorescent channel (a, c, e, g) and
corresponding images taken separately from the red fluorescent channel
demonstrating the results of the preabsorption procedure for neuropeptide
Y (P NPY, b), vasoactive intestinal polypeptide (P VIP, d), somatostatin
(P SOM, f) or Leu5-enkephalin (P L-ENK, h). The preabsorption of the
specific antiserum with an appropriate antigen completely eliminated
positive staining (b, d, f, h). Bar 100 μm (a–d, g, h), 50 μm (e, f)
Table 1 List of primary antisera and secondary reagents used (DβH dopamine β-hydroxylase, NPY neuropeptide Y, VIP vasoactive intestinal
polypeptide, SOM somatostatin, GAL galanin, L-ENK Leu5-enkephalin, nNOS neuronal nitric oxide synthase, FITC fluorescein isothiocyanate)
Antigen Code Dilution Host Supplier
Primary antibodies
DβH MAB 308 1:1000 Mouse Millipore, USA
NPY NA 1233 1:8000 Rabbit Enzo Life Sciences, USA
VIP VA 1285 1:4000 Rabbit Enzo Life Sciences, USA
SOM 11,180 1:4000 Rabbit ICN-Cappel, USA
GAL AB 5909 1:4000 Rabbit Millipore, USA
L-ENK EA 1149 1:9000 Rabbit Enzo Life Sciences, USA
nNOS AB 5380 1:16,000 Rabbit Millipore, USA
Secondary reagents
Biotinylated anti-rabbit immunoglobulins E 0432 1:1000 Goat Dako, Germany
CY3-conjugated strepatvidin 711-165-152 1:13,000 – Jackson, USA
FITC-conjugated anti-mouse IgG 715-096-151 1:700 Donkey Jackson, USA
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somata were L-ENK-immunopositive (1.1±0.8 %; Fig. 3j–l)
or nNOS-immunopositive (0.8±0.6 %; Fig. 3m–o).
Among FB+ non-adrenergic (DβH-) neurons, many
perikarya stained for NPY (27.2±12.7 %; Fig. 3a–c). Single
FB+/DβH- neurons (0.6±1.4 %) were SOM+ (Fig. 3g–i). No
FB+/DβH- nerve cells contained immunoreactivity to VIP,
GAL, L-ENK or nNOS.
Immunohistochemical characteristics of FB+ neurons
in BTX-treated animals
Double-labelling immunohistochemistry revealed that,
similar to the control group, the vast majority of FB+
Fig. 2 Bar diagram showing relative frequencies (%) of urinary bladder-
projecting neurons in sympathetic chain ganglia (SChG) of the control
pigs (n=5, open bars) and the BTX-treated animals (n=5, solid bars).
Each bar represents mean ± SD of pooled data from one pair of SChG
(pTh penultimate thoracic ganglion, hTh hindmost thoracic ganglion, L
lumbar ganglion, S sacral ganglion)
Fig. 3 Representative images of
SChG-UBPN in control pigs. All
images were taken separately
from blue (a, d, g, j, m), green
(b, e, h, k, n) and red (c, f, i, l, o)
fluorescent channels. a–c Seven
fast blue-positive (FB+) neurons
(a, blue, 5 long arrows, 1 short
arrow, 1 double arrow), which
were simultaneously DβH+
(b, green, 5 long arrows, 1 short
arrow) or DβH- (1double arrow)
and NPY+ (c, red, 5 long arrows,
1 double arrow) or NPY- (1 short
arrow). d–f Five FB+ neurons
(d, blue, 4 long arrows, 1 short
arrow), which were
simultaneously DβH+ (e, green,
4 long arrows, 1 short arrow) and
VIP+ (f, red, 4 long arrows) or
VIP- (1 short arrow). g–i Four
FB+ neurons (g, blue, 1 long
arrow, 2 short arrows, 1 double
arrow), which were
simultaneously DβH+ (h, green,
1 long arrow, 2 short arrows) or
DβH- (1 double arrow) and
SOM+ ( i, red, 1 long arrow, 1
double arrow) or SOM- (2 short
arrows). j–l Three FB+ neurons
(j, blue, 3 long arrows), which
were simultaneously DβH+
(k, green, 3 long arrows) and
L-ENK+ (l, red, 3 long arrows).
m–o Four FB+ neurons (m, blue,
1 long arrow, 3 short arrows),
which were simultaneously
DβH+ (n, green, 1 long arrow, 3
short arrows) and nNOS+ (o, red,
1 long arrow) or nNOS- (3 short
arrows). Bars 50 μm (a–f),
20 μm (g–o)
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UBPN (89.8±2.5 % in BTX-treated animals vs 91±
2.3 % in the control group) were DβH+ (Fig. 4b, e,
h, k, n). The remaining nerve cells (Fig. 4b, n) were
also DβH- (10.2±2.5 % in BTX-treated animals vs 9±
2.3 % in the control group).
However, in BTX-treated pigs, the percentages of
FB+ noradrenergic neuronal subpopulations distinctly
varied from those determined in the control animals
(Fig. 5). A lower number of FB+/DβH+/NPY+ neurons
(39.5±4.5 % vs 74.5±11.9 %) were observed in BTX-
treated pigs (Fig. 4a–c). Furthermore, in the toxin-
injected animals a decrease in the number of FB+/
DβH+ neurons immunopositive to VIP (8.9±5.3 % vs
22.3 %±8.8 %; Fig. 4d–f), SOM (5.8±2.3 % vs 17.4±
3.7 %; Fig. 4g–i) or GAL (0.9±1.2 % vs 5.4±4.4 %)
was observed. On the other hand, in BTX-injected pigs,
an increase in the number of the noradrenergic UBPN
immunoreactive to L-ENK (3.7±2.9 % vs 1.1±0.8 %;
Fig. 4j–l) or nNOS (7.7 ± 3.5 % vs 0.8 ± 0.6 %;
Fig. 4m–o) was observed.
In FB+/DβH- neurons, BTX treatment was followed
by a visible decrease in NPY+ (Fig. 4a-c) or SOM+
perikarya (8.4±3.3 % vs 27.2±12.7 % and 0 % vs 0.6±
1.4 %, respectively). As in the control pigs, no FB+/DβH-
neurons containing immunoreactivity to VIP, GAL, L-
ENK or nNOS were encountered.
Fig. 4 Representative images of
SChG-UBPN in BTX-treated
pigs. All images were taken
separately from blue (a, d, g, j,
m), green (b, e, h, k, n) and red (c,
f, i, l, o) fluorescent channels. a–c
Five FB+ neurons (a, blue, 1 long
arrow, 3 short arrows, 1 double
arrow), which were
simultaneously DβH+ (b, green,
1 long arrow, 3 short arrows) or
DβH- (1 double arrow) and
NPY+ (c, red, 1 long arrow, 1
double arrow) or NPY- (3 short
arrows). d–f Three FB+ neurons
(d, blue, 2 long arrows, 1 short
arrow), which were
simultaneously DβH+ (e, green,
2 long arrows, 1 short arrow) and
VIP+ (f, red, 2 long arrows) or
VIP- (1 short arrow). g–i Three
FB+ neurons (g, blue, 2 long
arrows, 1 short arrow), which
were simultaneously DβH+ (h,
green, 2 long arrows, 1 short
arrow) and SOM+ (i, red, 2 long
arrows) or SOM- (1 short arrow).
j–l Seven FB+ neurons (j, blue, 5
long arrows, 2 short arrows),
which were simultaneously
DβH+ (k, green, 5 long arrows, 2
short arrows) and L-ENK+ (l,
red, 5 long arrows) or L-ENK- (2
short arrows). m–o Three FB+
neurons (m, blue; 2 long arrows,
1 double arrow), which were
simultaneously DβH+ (n, green,
2 long arrows) or DβH- (1 double
arrow) and nNOS+ (o, red, 2 long
arrows) or nNOS- (1 double
arrow). Bars 50 μm (a–f, m–o),
20 μm (g–l)
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Discussion
The present results indicate that the SChG should be consid-
ered an important source of the autonomic innervation of
the urinary bladder in the female pig. This assumption corre-
sponds well with observations of other authors (Chien et al.
1991; Vera and Nadelhaft 1992; Houdeau et al. 1998) dealing
with the contribution of SChG to the innervation of various
internal organs including the bladder in the female rat. We
should emphasize that no morphological studies on the distri-
bution and chemical coding of SChG-UBPN in intact female
pigs have been performed so far. However, two such investi-
gations have been carried out in male animals (Ragionieri
et al. 2013; Pidsudko 2014). The distribution of SChG-
UBPN in male and female pigs is generally comparable.
Small differences observed between males and females might
result from the different allocation of injection sites of FB
chosen in the experiments or might represent sex-dependent
variations.
Pidsudko (2014) has found 1083±291.5, 1581±71.44 and
250±14.29 FB+ neurons in the SChG after the administration
of tracer to the bladder trigone, cervix or apex, respectively,
which together account for about 32 % of sympathetic nerve
cells involved in the innervation of the organ. These numbers
of neurons are smaller in comparison with those determined in
the present study (together 8226±1069 FB+ neurons in con-
trol pigs). As mentioned, this divergence is most probably a
consequence of a difference in the allocation of the FB injec-
tion sites employed in the experiments. Notably, Wakabayashi
et al. (1994) have found that adrenergic nerve fibres richly
supply not only the bladder base, but also the bladder body
(which was not injected with a tracer by Pidsudko 2014). The
other possible explanation might be related to sex-dependent
variations.
In this study, no significant differences in the number and
distribution of UBPN have been observed between the intact
and BTX-treated pigs. This finding corresponds well with the
observation of Apostolidis et al. (2005) who have demonstrat-
ed that the application of BTX into the human bladder
detrusor muscle has no influence on the number of
suburothelial nerve fibres visualized by immunohistochemis-
try with an antibody to pan-neuronal marker protein gene
product 9.5 (PGP 9.5) in bladder biopsies taken after toxin
administration. We can therefore conclude that, at least in both
humans and pigs, the mechanism of BTX action on the
bladder is not associated with neuronal death.
The chemical coding of porcine FB+ SChG-UBPN deter-
mined in this study is generally comparable with that observed
by other authors in the male pig (Ragionieri et al. 2013;
Pidsudko 2014). The vast majority of the retrogradely labelled
nerve cells in both females (91±2.3 %) and males (90 %;
Pidsudko 2014) are DβH+ suggesting their noradrenergic
nature. This observation is not surprising because the SChG
consist of mostly noradrenergic neurons providing a promi-
nent contribution to the noradrenergic nerve supply to various
internal organs (Kummer 1987; Heym et al. 1990; Skobowiat
et al. 2011). Many of the noradrenergic neurons observed in
the present study exhibit immunoreactivity to NPY and some
of them are immunostained for VIP, SOM, GAL, nNOS or L-
ENK. In general, similar biologically active substances have
been determined by Ragionieri et al. (2013) and Pidsudko
(2014) in porcine male SChG-UBPN and by other authors
(Hill and Elde 1989; Łakomy et al. 1994; Majewski 1999;
Skobowiat et al. 2011) in porcine SChG noradrenergic
neurons.
The present findings suggest that BTX is a factor evoking
strong adaptation changes in SChG-UBPN. We should em-
phasize that no morphological investigations dealing with the
influence of BTX on the chemical coding of SChG neurons
innervating the mammalian urinary bladder have been per-
formed previously. However, Wojtkiewicz et al. (2008) have
investigated BTX-induced changes in the chemical features of
IMG neurons supplying the porcine urinary bladder.
In the present study, the percentages of DβH+ SChG-
UBPN have been found to be similar in both the control and
BTX-treated pigs (91±2.3 % and 89.8±2.5 %, respectively).
We can therefore conclude that the toxin does not affect the
noradrenergic profile of these nerve cells. This observation
corresponds well with results of a previous study (Lepiarczyk
et al. 2011) that has revealed that BTX-treatment does not
decrease the number of DβH+ nerve fibres distributed in the
wall of the porcine female urinary bladder. As mentioned
before, the release of the sympathetic neurotransmitter nor-
adrenaline (NA) allows continence to be achieved (Andersson
and Arner 2004; Morrison et al. 2005). Thus, the unchanged
Fig. 5 Bar diagram showing relative frequencies (%) of subpopulations
of noradrenergic (DβH+) retrogradely labelled (FB+) bladder-projecting
neurons in sympathetic chain ganglia (SChG) of control pigs (n=5, open
bars) and BTX-treated animals (n=5, solid bars). Each bar represents
mean ± SD of pooled data from bilateral L3, L5 and S2 SChG (DβH
dopamine β-hydroxylase, NPY neuropeptide Y, VIP vasoactive intestinal
polypeptide, SOM somatostatin, GAL galanin, L-ENK Leu5-enkephalin,
nNOS neuronal nitric oxide synthase). Statistically significant differences:
**P≤0.01, ***P≤0.005
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relative frequency of noradrenergic neurons observed in the
present study can be considered as an advantageous finding
from the perspective of the use of BTX in the treatment of
urinary bladder disorders involving the overactivity of the
bladder detrusor and might be the reason for good clinical
results.
Although the numbers of noradrenergic SChG-UBPN are
similar in the intact and BTX-treated pigs, the present study
has revealed that the expression of some biologically active
substances in these nerve cells distinctly differ between the
two groups. In general, the administration of the toxin results
in a significant decrease in the number of the noradrenergic
neurons expressing NPY, VIP, SOM and GAL but an increase
in the number of the neurons stained for L-ENK and nNOS.
Similar results have been obtained by Wojtkiewicz et al.
(2008) who have observed a significant decrease in the num-
ber of NPY+ and VIP+ noradrenergic UBPN in the porcine
female IMG after the application of BTX into the wall of the
organ. However, in contrast to the present findings,
Wojtkiewicz et al. (2008) have found an increase in the
number of the neurons expressing SOM.
The changes in the expression of NPY, VIP and SOM in
particular are intriguing, because immunoreactivities to these
substances have been found in many noradrenergic SChG-
UBPN in normal (intact) pigs and, thus, the role that they play
can also be considered as proportionally significant. We
should also keep in mind that all the substances mentioned
are expressed in noradrenergic neurons, thus, in both the intact
and BTX-treated animals, they most probably function as
neuromodulators or co-transmitters in relation to the main
neurotransmitter, NA. As previously mentioned, the positive
effect of BTX on urinary bladder disorders in humans is
thought, in general, to be associated with a withdrawal of the
cholinergic input and thus with the achievement of the
prevalence of the noradrenergic involvement. We are
therefore tempted to assume that the significance of the
changes in the expression of the various active substances in
the noradrenergic neurons observed in the present study is to
accomplish the enhancement of the contribution of the
noradrenergic nerve supply. This hypothesis is supported by
some interesting observations dealing with the influence of
NPYon noradrenergic transmission in urogenital organs. Tran
et al. (1994) have found that this peptide exerts a prejunctional
inhibitory effect on noradrenergic transmission in the rat lower
urinary tract. Moreover, NPY has been established to depress
the release of NA from nerves supplying the rat vas deferens
(Lundberg and Stjarne 1984; Bitran et al. 1996) and seminal
vesicle (Iravani and Zar 1994) or rabbit oviduct (Chernaeva
and Charakchieva 1988). The decrease in the expression of
NPY in the subpopulation of noradrenergic neurons observed
in the present study can therefore be assumed to result in the
reduction of the inhibitory effect of this peptide on noradren-
ergic transmission and thus to improve continence. The
significance of a decrease in the expression of VIP, SOM
and GAL is probably also involved with the enhancement of
NA release. The literature in the field contains information
justifying this idea, however, the relevant data have not been
obtained in studies performed on urinary tract tissues. VIP has
been found to inhibit the release of NA from nerves supplying
the rat portal vein (Bråtveit and Helle 1991). SOM has been
revealed to inhibit the release of NA from rat hypothalamic
neurons (Göthert 1980), rat mesenteric artery (Calhau et al.
2000) and rabbit ear artery (Maynard et al. 1991). GAL
(together with NPY) has been observed to significantly inhibit
the stimulation-evoked NA release in the rat hypothalamus
(Tsuda et al. 1989) and medulla oblongata (Tsuda et al. 1992).
On the other hand, an increase in the expression of nNOS
and L-ENK suggests that both nitric oxide (NO) and L-ENK
can act as co-transmitters supporting NA in affecting bladder
smooth muscle contraction. NO, a substance well recognized
as also exerting smooth muscle relaxation in urogenital organs
(Persson et al. 1993; Burnett 1995) can be assumed to poten-
tiate the relaxatory effect of NA on the detrusor muscle
mediated via β adrenergic receptors. Opioid peptides, in turn,
have been found to evoke rapid long-lasting contractile effects
on the female rat intrinsic urethral sphincter (Crayton et al.
2010). Because, as mentioned before, NA also excites the
bladder base and urethra musculature via α1-adrenoreceptors,
L-ENK can be considered to assist NA in this action.
The present study has revealed a small (9±2.3 % in the
control group vs 10.2±2.5 % in BTX-treated animals) popu-
lation of non-adrenergic (DβH-) SChG-UBPN.Many of these
nerve cells immunostain for NPY and the solitary neuronal
somata are SOM+. The most significant finding involving the
chemical coding of these neurons is a distinctly lower number
of especially NPY+ perikarya in BTX-treated pigs. We
should mention that Pidsudko (2014) has revealed that small
numbers of SChG-UBPN in the male pig express VAChT (a
cholinergic marker) or neither VAChT nor DβH. We can
therefore assume that, in the female pig, BTX affects the
cholinergic (or even non-adrenergic, non-cholinergic) trans-
mission in SChG-UBPN via the down-regulation of NPY
expression.
In conclusion, the present study has revealed the existence
of profound differences in the chemical coding of the SChG-
UBPN between normal female pigs and pigs after intravesical
BTX injections. The most important findings include a sig-
nificant decrease in the number of the noradrenergic neurons
expressing NPY, VIP, SOM and GAL and an increase in the
number of the neurons expressing nNOS and L-ENK. We can
hypothesize that, in the toxin-administered animals, these
changes cause the enhancement of the noradrenergic input to
the bladder tissues thereby constituting an additional (to that
involving the cholinergic transmission) beneficial effect of
BTX treatment. Therefore, the present study has, for the first
time, provided evidence that the therapeutic effects of BTX on
270 Cell Tissue Res (2015) 360:263–272
the mammalian urinary bladder is partly mediated by SChG
neurons.
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source are credited.
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